The receptor hypothesis

Nicotinic acid binds GPR109A (also called HCA2 or HCAR2), a G-protein-coupled receptor expressed on immune cells — macrophages, dendritic cells, neutrophils, and colonic epithelial cells. This binding triggers a signaling cascade that shifts the immune system toward anti-inflammatory regulation.

The key steps: GPR109A activation → prostaglandin D2 release → promotion of regulatory T cells (Treg) → increased IL-10 (an anti-inflammatory cytokine) → suppression of NF-kB-mediated inflammation.

This pathway is specific to nicotinic acid. Niacinamide does not activate GPR109A. Neither does NR or NMN. This specificity is the strongest argument that nicotinic acid's immune effects operate through GPR109A rather than through NAD+ metabolism alone.

Evidence in the gut

The most robust evidence comes from colitis models. Multiple studies demonstrate that GPR109A activation by nicotinic acid (or its endogenous agonist butyrate) suppresses colonic inflammation and carcinogenesis. Knockout mice lacking GPR109A lose the protective effect entirely.

In a striking human study, 26 patients with moderate ulcerative colitis unresponsive to conventional treatment received daily niacin enemas for 6 weeks. 92.3% responded positively and 88.5% achieved clinical remission — mediated through prostaglandin D2 and the D prostanoid receptor 1 pathway.

Evidence in the brain

GPR109A is expressed in microglia and macrophages in the central nervous system. Niacin treatment reactivates myeloid cells in brain tumor models, reducing tumor size and prolonging survival. Separate evidence shows GPR109A-dependent neuroprotection through the β-hydroxybutyrate receptor pathway, activating a protective subset of macrophages.

For Parkinson's disease, niacin supplementation may operate through three concurrent GPR109A-related mechanisms: reduced neuroinflammation, increased dopamine production via NADPH, and improved mitochondrial function.

Evidence in the skin

Psoriatic skin shows decreased expression of GPR109A. Topical sodium butyrate (another GPR109A agonist) can restore receptor expression. This suggests a feedback loop: chronic inflammation downregulates the receptor that would help resolve it, and exogenous GPR109A agonists can break the cycle.

Evidence in macrophage function

Activated GPR109A inhibits chemoattractant-mediated macrophage migration via the Gβγ/PKC/ERK1/2 pathway. Niacin shifts macrophages from proinflammatory to anti-inflammatory phenotypes — a mechanism with implications across multiple autoimmune conditions.

Inflammation itself upregulates GPR109A expression in adipose tissue and macrophages, suggesting a built-in amplification loop: the more inflamed the tissue, the more responsive it becomes to nicotinic acid signaling.

What remains unknown

  • Human dose-response: Most GPR109A evidence comes from animal models. The dose at which GPR109A-mediated immune effects become clinically significant in humans is poorly characterized.
  • Tissue-specific activation: GPR109A is expressed differently across tissues. Whether systemic nicotinic acid supplementation activates the receptor sufficiently in all relevant tissues (gut, brain, skin, joints) is unclear.
  • Duration effects: Long-term GPR109A activation patterns are unstudied. Does the receptor desensitize? Does the immune shift persist after discontinuation?
  • Interaction with other pathways: GPR109A effects overlap with NAD+ metabolism effects. Isolating the receptor-specific contribution from the metabolic contribution remains difficult.

Supporting studies

cohortpositivenicotinic-acidhuman

Relationship between dietary niacin intake and erectile dysfunction: a population-based study

A large U.S. study found men with higher dietary niacin (vitamin B3) intake had a lower risk of erectile dysfunction (ED). Men in the highest third of niacin intake were 56% less likely to have ED compared to those in the lowest third. This link held true even after accounting for other factors like age, weight, and health conditions.

rctpositivenicotinic-acidhuman

Niacin ameliorates ulcerative colitis via prostaglandin D2‐mediated D prostanoid receptor 1 activation

Out of 26 patients with moderate ulcerative colitis (inflammation of the colon) who were unresponsive to conventional treatments, 92.3% responded positively and 88.5% went into remission after receiving a daily niacin enema treatment for 6 weeks. The had no serious side effects, showed notable improvements in intestinal healing, reduced symptoms like rectal bleeding and stool frequency. Niacin is a promising, well-tolerated alternative for inducing clinical remission of ulcerative colitis.

rctpositivenicotinic-acid1g HEDhuman

Intravenous Niacin Acutely Improves the Efficiency of Dietary Fat Storage in Lean and Obese Humans

24 healthy men and women with a mean age of 35 years, where injected Intravenously w/ 1g of niacin or placebo for 2 weeks. The niacin group ended up with acutely lower levels of FFAs (free fatty acids, fats floating around in the bloodstream) and significantly higher levels of triglyceride stored in visceral adipose tissue. This may help to reduce the amount of fat that is stored in the liver and other organs, which can help to improve insulin sensitivity and reduce the risk of metabolic complications. IE niacin may help people with diabetes and obesity to lose weight and improve their health.

ecologicalpositivenicotinic-acidhuman

Vitamin b3 and Seborrheic dermatitis - a phase IV clinical study of FDA data

Study of 4,269 people that take niacin or have Seborrheic dermatitis finds no cases of Seborrheic dermatitis in people who take niacin.

reviewpositivenicotinic-acidn/a

Emerging roles of GPR109A in regulation of neuroinflammation in neurological diseases and pain

Summary of GPR109A (niacin receptor) role in inflammation of the nervous system, especially the brain, and how activation of GPR109A plays a role in healing may conditions such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, stroke, and pathological pain.

animalpositivenicotinic-acid0.121g HEDrat

Deficiency of metabolite sensing receptor HCA2 impairs the salutary effect of niacin in hemorrhagic shock

Niacin improves organ function and survival following hemorrhagic shock. Rats and mice where bled 60% of their blood volume, and replaced with Ringers lactate solution to induce hemorrhagic shock ( deprive tissue of oxygen and blood ). After 10 minutes of shock the animals where split into 3 groups and injected with nicotinic acid, NMN or DMSO, at 3 levels of dosing. Niacin at 10mg/kg, which was the highest dose given, had by far the best level of survivability. Rats, given NMN even at a 5x higher dose than niacin at 50mg/kg did not achieve a survival rate to the level observed in the 10mg/kg or the even 5mg/kg treated mice. Use of GPR109A knockout mice confirmed that the niacin GPR109A receptor plays a major role in the survivability enhancing effect of niacin.

case-reportpositivenicotinic-acid1.5g HEDhuman

Reversing Chronic Kidney Disease with Niacin and Sodium Bicarbonate

25 individuals with CKD (chronic kidney disease) stages 2-4 treated with a combination of supplements, including 500mg niacin 3x/day for three months, improved the disease by at least one stage.

animalpositivenicotinic-acidmouse

The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages

Nicotinic acid mimics the effect of a ketogenic diet in activating HCA2, which induces a neuroprotective phenotype in bone marrow-derived macrophages that infiltrate the brain and that this results in an improved outcome in a mouse model of stroke.

cohortpositivenonehuman

Plasma acetylcholine and nicotinic acid are correlated with focused preference for photographed females in depressed males: an economic game study

This study showed depressed males have a narrower preference for female photographs (only preferring good looking ones) which is a marker for lower cognitive flexibility. The less nicotinic acid in their body, the narrower their preference. This indicates nicotinic acid may regulate human social decision-making (especially preference-related behaviors) by acting on the HCAR2 in microglia (the resident immune cells of the brain and spinal cord which constantly patrol the cerebral microenvironment to respond to pathogens and damage).

animalpositivenicotinic-acidn/a

Effect of Different Levels of Niacin on Serum Biochemical Parameters, Antioxidant Status, Cytokine Levels, Inflammatory Gene Expression and Colonic Microbial Composition in Weaned Piglets

Piglets separated from their mother in agriculture tend to struggle health wise. Supplementing their diet with niacin significantly improves their survivability via factors like improved colonic microbial diversity, intestinal health, reduced intestinal inflammation and improved overall immunity.

in-vitropositivenicotinic-acidcell-line

Action of nicotinic acid on the reversion of hypoxic-inflammatory link on 3T3-L1 adipocytes

Niacin reduces inflammation caused by low levels of oxygen in tissue that is associated with obesity.

cohortpositivenicotinic-acid3g HEDhuman

Niacin reduces abdominal fat: pilot study

Participants in an open label study at Kaiser Permanente in San Francisco supplemented ~3g niacin a day. After about 1 year, 81% of patients had an by an average reduction of 27% in intra-abdominal fat. The degree of fat loss was associated with the degree of increase in HDL cholesterol and a reduced Total Cholesterol/HDL cholesterol ratio.

animalpositivenicotinic-acidmouse

Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis

Niacin, a pharmacological Gpr109a agonist, suppressed colitis and colon cancer in a Gpr109a-dependent manner in mice. Thus, Gpr10a has an essential role in mediating the beneficial effects of gut microbiota and dietary fiber in colon.

mechanisticpositivenicotinic-acidmouse

Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages

Many of the beneficial and adverse effects of niacin are mediated via GPR109, which is highly expressed in adipose tissue and macrophages. Multiple infectious and inflammatory stimuli stimulate GPR109A expression in adipose tissue and in macrophages.

reviewpositivenicotinic-acidhuman

Antiatherothrombotic effects of nicotinic acid

Niacin reduces blood viscosity through a variety of mechanisms, thus improving blood flow and perfusion through choke points of the vasculature. Finally, niacin has cardioprotective effects that may limit ischemia–reperfusion injury. By preserving glycolysis during periods of inadequate blood supply and improving blood flow to the heart after a stroke, niacin can improve the functional recovery of the muscular tissue of the heart.

rctmixedcombinationhuman

Effects of an oral mixture containing glycine, glutamine and niacin on memory, GH and IGF-I secretion in middle-aged and elderly subjects

42 people drank a 10g mixture of glycine, glutamine and niacin daily for 3 weeks saw an increase in serum growth hormone (GH) levels by 70%, but this GH increase was not associated with improvement in mood or memory. Circulating Insulin-like growth factor 1 (IGF-I) levels did not change.

animalpositivenicotinic-acidmouse

Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis

GPR109A expressed in immune cells as well as in colonic tissue is necessary for protection against colitis and colon carcinogenesis. Niacin suppresses colitis and colon cancer in a GPR109A-dependent manner. GPR109A is key in mediating the beneficial effects of gut microbiota and dietary fiber in colon. Niacin suppresses atherosclerosis by activating GPR109A in immune cells. GPR109A mediates butyrate effects in colon and is a critical molecular link between colonic bacteria and dietary fiber and the host.

in-vitropositivenicotinic-acidcell-line

Niacin Reverses Migratory Macrophage Foam Cell Arrest Mediated by oxLDL In Vitro

Oxidized Low Density Cholesterol, oxLDL induced inhibition of macrophage migration may be reversed by Niacin, which explains part of Niacin's atheroprotective effects on cardiovascular disease independent of its effects on plasma lipids. Macrophage foam cells are a type of macrophage that localize to fatty deposits on blood vessel walls. Niacin also inhibited the formation of peroxynitrite (which is a powerful oxidant exhibiting a wide array of tissue damaging effects)

mechanisticneutralnicotinic-acidcell-line

Nicotinic Acid is a Common Regulator of Heat-Sensing TRPV1-4 Ion Channels

NA activates the capsaicin receptor TRPV1 by lowering the activation threshold for heat, causing channel activation at physiological body temperature. Conversely it inhibits TRPV4 by raising activation temp to above body temp, ~41 celsius. Overall, the effects on TRPV1 and TRPV3 are potentiating while those on TRPV2 and TRPV4 are inhibitory. Little is known about the detailed structures of TRPV2-4. The TRPV receptors play a role in the flushing response.

in-vitropositivenicotinic-acidcell-line

Anti-inflammatory effects of nicotinic acid

Niacin has multi-faceted anti inflammatory properties that act in both localized and systemic ways. A major area of its activity is in tissue related to fat storage via the GPR109A receptor. Dosing cells with TNF-alpha ( an inflammatory substance ) showed that niacin treated cells increased the atheroprotective hormone adiponectin and reduced macrophage chemotaxis

in-vitropositivenicotinic-acidcell-line

Niacin attenuates the production of pro-inflammatory cytokines in LPS-induced mouse alveolar macrophages by HCA2 dependent mechanisms

Explores protective effect of niacin on lung tissue by dosing mouse lung white blood cells with niacin and exposing them to inflammatory toxins (Lipopolysaccharides). This demonstrated strong anti-inflammatory effects of niacin ( reduced levels of TNF-α, IL-6 and IL-1β) and that the protective effect depends on expression of GPR109A.

animalpositivenicotinic-acidrat

Niacin attenuates lung inflammation and improves survival during sepsis by downregulating the nuclear factor-κB pathway

Rats injected with e coli bacteria to induce lung inflammation survived better with high dose (~1% of diet) niacin supplementation. The reduced lung inflammation and damage was associated with downregulation of the NF-κB (Nuclear Factor Kappa B) pathway.

animalpositivecombinationrat

Physiological and Anti-obesity Effects of Melatonin and Niacin Supplements in Rat Models

Rats where given unlimited access to food and a controlled amount of exercise. Those taking niacin + melatonin lost statistically significantly more weight, compared to control, niacin only and melatonin only groups. Suggests a synergy between niacin & melatonin supplementation for anti-obesity. It's noted that mice lacking the niacin receptor GPR109A had progressive weight gain and liver fat accumulation.

cohortpositivebutyratehuman

Decreased expression of G-protein-coupled receptors GPR43 and GPR109a in psoriatic skin can be restored by topical application of sodium butyrate

Psoriatic skin has reduced GPR109A expression, topical sodium butyrate increases GPR109A expression in skin and is potentially useful in psoriasis therapy.

in-vitropositivenicotinic-acidcell-line

The Niacin/Butyrate Receptor GPR109A Suppresses Mammary Tumorigenesis by Inhibiting Cell Survival

The expression of niacin receptor GPR109A is decreased by over 70% in breast cancer samples. It's reduced in early stages, and almost undetectable in advanced stages. Increasing expression of GPR109A seems to act as a tumor suppressor in breast tissue, but interestingly can also acts as tumor protective in other tissues like skin, mechanism of differentiation unknown.

in-vitropositivenicotinic-acidcell-line

Small Molecule Antagonists of NAADP-Induced Ca2+ Release in T-Lymphocytes Suggest Potential Therapeutic Agents for Autoimmune Disease

Ca2+ is one of the major ways that cells communicate and is involved in the regulation of many important cellular processes from proliferation to apoptosis. Ca2+ regulation is involved in many autoimmune conditions and nicotinic acid (niacin) and is key to this signaling.

mechanisticpositivenicotinic-acidn/a

Network Pharmacology and bioinformatics analyses identify intersection genes of niacin and COVID-19 as potential therapeutic targets

Computer modeling shows niacin a key to therapy for covid via enhancing the immune system, inhibiting inflammation and regulating cellular microenvironment.

animalpositivenicotinic-acidmouse

Control of brain tumor growth by reactivating myeloid cells with niacin

Niacin treatment of mice bearing intracranial brain tumor initiative cells increased macrophage representation within the tumor, reduced tumor size, and prolonged survival.

animalpositivenicotinic-acidmouse

Niacin Attenuates Pulmonary Hypertension Through H-PGDS in Macrophages

When mice are induced with pulmonary hypertension via drugs and low oxygen, those on niacin have less severe outcomes, due to enhanced macrophage activity and release of PGD2.

animalpositivenicotinic-acidmouse

Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system

Niacin via its ability to enhance macrophage and microglia is great for repairing (myelin) sheaths that protect nerve fibers, which deteriorate in diseases like multiple sclerosis.

in-vitropositivenicotinic-acidcell-line

Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin

Adipose tissue (body tissue used for the storage of fat) is major site of action for niacin. When adding a white blood cell attractant to adipose tissue, niacin suppresses the pro-atherogenic (plaque inducing) chemokines and upregulates the atheroprotective (protective against plaque and improves metabolism of sugar) adiponectin.

animalpositivenicotinic-acidn/a

Nicotinic acid inhibits vascular inflammation via the SIRT1-dependent signaling pathway

Feeding rabbits Niacin up-regulated SIRT1 expression, which is involved with DNA repair. Rabbits where then subjected to stress via a collar on an artery in their neck and it was shown that niacin protects against blood vessel inflammation via the SIRT1/CD40-dependent signaling pathway.

reviewpositivenicotinic-acidhuman

Niacin in the Central Nervous System: An Update of Biological Aspects and Clinical Applications

In depth review of how niacin and its metabolites play a key role in brain and nerve health. Alzheimers and Niacin intake are inversely correlated. Niacin helps cells stay alive when blood supply is cutoff.

animalpositivemelatoninmouse

Melatonin alleviates titanium nanoparticles induced osteolysis via activation of butyrate/GPR109A signaling pathway

Supplementing mice with melatonin increases butyrate production in their gut via bacteria, conversely antibiotics severely impair this butyrate production. When mice are poisoned with titanium nanoparticles to induce bone deterioration, butyrate has a protective effect against bone loss. This protective effect is specifically dependent on the GPR109A receptor that seems to be activated by the butyrate enriched gut microbiota.

in-vitropositivenicotinic-acidcell-line

Activated niacin receptor HCA2 inhibits chemoattractant-mediated macrophage migration via Gβγ/PKC/ERK1/2 pathway and heterologous receptor desensitization

GPR109A (aka HCA2) is highly expressed in immune cells and together with niacin seems to inhibit proinflammatory aspects of immune cell activity.

reviewpositivenicotinic-acidhuman

A novel treatment target for Parkinson's disease

The GPR109A receptor and its agonists (niacin and butyrate) have anti-inflammatory actions in the skin, gut and retina. For Parkinson's disease, niacin supplementation may have 3 benefits: lower inflammation via GPR109A-related mechanisms, increase dopamine production in brain by supplying NADPH and boosting mitochondrial functions by increasing the NAD/NADH ratio.

animalpositivenicotinic-acidmouse

Activation of the receptor (Gpr109a) for niacin and the commensal metabolite butyrate suppresses colonic inflammation and carcinogenesis

GPR109A plays an essential role in gut health. GPR109A deficiency worsens colitis and colonic inflammation in mice. GPR109A expression is necessary for immune health. Antibiotics mess up butyrate producing gut bacteria, thus reducing GPR109A.

animalpositivenicotinic-acidmouse

Niacin fine-tunes energy homeostasis through canonical GPR109A signaling

When fed a high fat diet + niacin, mice deficient in niacin receptor GPR109A got fat and had fatty livers. While mice with normal GPR109A receptors didn't get fat and didn't end up with fatty livers.

rctpositivenicotinic-acid2g HEDhuman

Niacin for treatment of nonalcoholic fatty liver disease (NAFLD): novel use for an old drug?

39 patients taking 2g/day extended release niacin for ~6 months had a ~40% reduction in liver fat. Other markers of inflammation such as CRP (C-reactive protein) where also reduced.

reviewpositivenicotinic-acidhuman

Niacin and its metabolites as master regulators of macrophage activation

The focus is on how niacin and its metabolites enable white blood cells to react to a changing microenvironment (macrophage plasticity). It also discusses the anti-oxidant and anti-inflammatory aspects of niacin.

← All pathways